Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.
Cancer Cytopathol. 2018 May;126(5):309-316. doi: 10.1002/cncy.21981. Epub 2018 Feb 9.
The recent revision in terminology, with noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) replacing noninvasive follicular variant of papillary thyroid carcinoma, has reclassified the clinically indolent tumor as nonmalignant. The objective of this study was to evaluate the impact of this change on the rate of malignancy (ROM) for subcategories of an atypia of undetermined significance (AUS) diagnosis on fine-needle aspiration (FNA) cytology.
Consecutive thyroid FNAs interpreted as AUS over a period of 4 years were retrospectively analyzed. The ROM for AUS subcategories, including atypia of undetermined significance with nuclear atypia (AUS-N), atypia of undetermined significance with a microfollicular pattern (AUS-F), atypia of undetermined significance with nuclear atypia and a microfollicular pattern (AUS-N/F), atypia of undetermined significance with Hürthle cells (AUS-H), and atypia of undetermined significance, not otherwise specified (AUS-NOS), were analyzed.
Of the 426 nodules interpreted as AUS, 244 were surgically excised. The incidence of NIFTP in each subcategory was as follows: 18% for AUS-N, 18% for AUS-F, 9% for AUS-N/F, 3% for AUS-H, and 0% for AUS-NOS. After the reclassification of NIFTP as nonmalignant, the ROM based on histologic follow-up significantly decreased from 43% to 26% for AUS-N (P < .001) and from 29% to 10% for AUS-F (P = .008). The ROM for AUS-N remained significantly higher than the ROM for AUS-F (P = .030).
A subset of resected AUS nodules can be reclassified as NIFTP, and that significantly decreases the ROM, especially for AUS-N and AUS-F. Nonetheless, AUS-N still harbors a substantially higher ROM than AUS-F. Cancer Cytopathol 2018;126:309-16. © 2018 American Cancer Society.
最近术语的修订,将具有滤泡状甲状腺肿瘤特征的非侵袭性滤泡性肿瘤(NIFTP)取代非侵袭性滤泡状甲状腺癌的变体,将临床上惰性肿瘤重新分类为非恶性。本研究的目的是评估这一变化对细针抽吸(FNA)细胞学中不确定意义的非典型性(AUS)诊断亚类的恶性肿瘤率(ROM)的影响。
回顾性分析了连续 4 年期间诊断为 AUS 的甲状腺 FNA。对 AUS 亚类的 ROM 进行了分析,包括核异型性的不确定意义的非典型性(AUS-N)、具有微滤泡模式的不确定意义的非典型性(AUS-F)、具有核异型性和微滤泡模式的不确定意义的非典型性(AUS-N/F)、具有 Hurthle 细胞的不确定意义的非典型性(AUS-H)和未特指的不确定意义的非典型性(AUS-NOS)。
在 426 个被诊断为 AUS 的结节中,有 244 个进行了手术切除。每个亚类中 NIFTP 的发生率如下:AUS-N 为 18%,AUS-F 为 18%,AUS-N/F 为 9%,AUS-H 为 3%,AUS-NOS 为 0%。在将 NIFTP 重新分类为非恶性后,基于组织学随访的 ROM 从 AUS-N 的 43%显著下降至 26%(P <.001),从 AUS-F 的 29%显著下降至 10%(P =.008)。AUS-N 的 ROM 仍显著高于 AUS-F(P =.030)。
一部分切除的 AUS 结节可以重新分类为 NIFTP,这显著降低了 ROM,特别是对于 AUS-N 和 AUS-F。尽管如此,AUS-N 仍然比 AUS-F 具有更高的 ROM。癌症细胞病理学 2018;126:309-16。© 2018 美国癌症协会。